The R&D department of pharmaceutical company GSK will undergo a ‘change programme’ in a bid to save at least £1 billion by 2016, the company has said.
GSK will also look at its manufacturing operations as part of the programme, which aims to roll out good working practices from particular R&D locations to all other R&D locations.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.